Exdensur (depemokimab) is the first and only ultra-long-acting biologic in the EU to treat severe asthma and chronic rhinosinusitis with nasal polyps ...
A new way for clinicians to refer people with asthma for advice and support aims to provide benefits for patients and the wider health service, writes Michael McHale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results